Dolutegravir Tivicay Triumeq Medications

Dolutegravir Info

What is Dolutegravir?

Dolutegravir is a medication that belongs to the class of integrase strand-transfer inhibitors. It works by stopping HIV from inserting its genetic material into human cells. In Hong Kong, dolutegravir is available in several branded and generic products that are used as part of antiretroviral therapy.

Medications with Dolutegravir

A number of medicines sold in Hong Kong contain dolutegravir, either alone or in combination with other HIV drugs.

• Triumeq - a fixed-dose tablet that combines dolutegravir with abacavir and lamivudine. It is marketed for adults who need a single-pill regimen.
• Viropil - another single-tablet option that pairs dolutegravir with tenofovir disoproxil fumarate and emtricitabine. It is commonly prescribed for treatment-naïve patients.
• Tivicay - a tablet that contains dolutegravir as the sole active ingredient, allowing clinicians to add other antiretrovirals as needed.

These products are supplied as oral tablets in strengths ranging from 25 mg (Tivicay) to 50 mg per tablet (Triumeq, Viropil). Both brand-name and generic versions are approved by the Hong Kong Department of Health and can be obtained from community pharmacies with a prescription.

What Does Dolutegravir Treat?

Dolutegravir is used to manage infection with the human immunodeficiency virus (HIV). It is an essential component of combination antiretroviral therapy (cART), which aims to:

• Reduce the amount of virus in the blood (viral load) to undetectable levels.
• Preserve or improve the immune system’s CD4 cell count, helping the body fight infections.
• Decrease the risk of HIV-related complications and improve long-term health outcomes.

Because HIV quickly develops resistance to single drugs, dolutegravir is almost always prescribed with two other antiretrovirals, as seen in Triumeq and Viropil. The combination approach is recommended for adults and adolescents living with HIV across Hong Kong. While its primary indication is treatment, clinicians may also include dolutegravir-based regimens in prevention strategies under specialist supervision.

How Dolutegravir Works

Dolutegravir blocks the HIV integrase enzyme, which the virus needs to splice its DNA into the host cell’s genome. By halting this step, the drug prevents new infected cells from forming. The effect begins shortly after the tablet is absorbed, and viral suppression typically becomes evident within a few weeks when used as part of a full regimen.

Safety Information

Common Side Effects

People taking dolutegravir-containing medicines often report mild, temporary effects such as:

• Headache
• Fatigue or feeling tired
• Nausea or mild stomach upset

These symptoms usually lessen as the body adapts to the medication. Over-the-counter remedies for nausea may be used, but any new or worsening symptom should be noted.

Serious Reactions

Rare but important reactions can occur, including:

• Severe allergic responses (e.g., rash, swelling of the face, difficulty breathing)
• Signs of liver trouble (yellowing of the skin or eyes, dark urine)

If any of these appear, immediate medical attention is required.

Who Should Be Cautious

Certain groups need extra care when using dolutegravir:

• Pregnant individuals - the drug is generally considered safe, but clinicians weigh benefits against potential risks.
• People with significant kidney or liver impairment - dose adjustments or alternative therapies may be needed.
• Individuals with known hypersensitivity to dolutegravir or any component of the tablet.

Interaction Awareness

Dolutegravir can interact with other medicines and substances:

• Antacids containing aluminium or magnesium may reduce absorption; separating intake by a few hours is advisable.
• Some anticonvulsants and rifampicin can lower dolutegravir levels, potentially affecting effectiveness.
• Alcohol does not directly interfere, but excessive consumption may worsen side effects such as nausea.

For a full list of interactions, refer to the specific product leaflets.

What to Know Before Using

Store dolutegravir tablets at room temperature, away from moisture and direct sunlight. The medication is intended for short-term initiation followed by long-term maintenance, depending on the individual’s treatment plan. Because strengths and combinations differ between Triumeq, Viropil, and Tivicay, always follow the instructions printed on the packaging of the exact product prescribed.

For detailed usage, dosing, administration, refer to your specific medication’s information.

Key Terms

Integrase inhibitor: A drug that stops HIV from inserting its genetic material into a host cell.

Viral load: The amount of HIV RNA found in the blood, measured to assess treatment success.

CD4 cell count: A blood test that reflects immune system strength; higher counts are better.

cART (combination antiretroviral therapy): The practice of using three or more antiretroviral drugs together to control HIV infection.

Information Disclaimer

This article offers general educational information about dolutegravir as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dolutegravir may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.